Document is current

Any future updates will be listed below

Associated adverse outcomes with tumor treating fields when combined to temozolomide versus temozolomide alone for the treatment of glioblastoma: a meta-analysis of randomized trials

Crossref DOI link: https://doi.org/10.1186/s41984-025-00342-8

Published Online: 2025-02-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark